GNGBY
Price
$22.86
Change
+$0.14 (+0.62%)
Updated
Sep 23 closing price
Capitalization
6.16B
IRME
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 23 closing price
Capitalization
3.95M
70 days until earnings call
Interact to see
Advertisement

GNGBY vs IRME

Header iconGNGBY vs IRME Comparison
Open Charts GNGBY vs IRMEBanner chart's image
Getinge AB
Price$22.86
Change+$0.14 (+0.62%)
Volume$212
Capitalization6.16B
IR-Med
Price$0.05
Change-$0.00 (-0.00%)
Volume$12.08K
Capitalization3.95M
GNGBY vs IRME Comparison Chart in %
Loading...
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GNGBY vs. IRME commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNGBY is a Hold and IRME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GNGBY: $22.86 vs. IRME: $0.05)
Brand notoriety: GNGBY and IRME are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: GNGBY: 9% vs. IRME: 10%
Market capitalization -- GNGBY: $6.16B vs. IRME: $3.95M
GNGBY [@Medical/Nursing Services] is valued at $6.16B. IRME’s [@Medical/Nursing Services] market capitalization is $3.95M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $236.51B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNGBY’s FA Score shows that 2 FA rating(s) are green whileIRME’s FA Score has 0 green FA rating(s).

  • GNGBY’s FA Score: 2 green, 3 red.
  • IRME’s FA Score: 0 green, 5 red.
According to our system of comparison, GNGBY is a better buy in the long-term than IRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNGBY’s TA Score shows that 2 TA indicator(s) are bullish while IRME’s TA Score has 5 bullish TA indicator(s).

  • GNGBY’s TA Score: 2 bullish, 5 bearish.
  • IRME’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IRME is a better buy in the short-term than GNGBY.

Price Growth

GNGBY (@Medical/Nursing Services) experienced а -0.09% price change this week, while IRME (@Medical/Nursing Services) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.84%. For the same industry, the average monthly price growth was +5.78%, and the average quarterly price growth was +11.05%.

Reported Earning Dates

IRME is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.84% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNGBY($6.16B) has a higher market cap than IRME($3.95M). GNGBY YTD gains are higher at: 50.463 vs. IRME (-89.733). GNGBY has higher annual earnings (EBITDA): 5.51B vs. IRME (-1.45M). GNGBY has more cash in the bank: 1.95B vs. IRME (63K). IRME has less debt than GNGBY: IRME (250K) vs GNGBY (11.2B). GNGBY has higher revenues than IRME: GNGBY (35.5B) vs IRME (0).
GNGBYIRMEGNGBY / IRME
Capitalization6.16B3.95M156,119%
EBITDA5.51B-1.45M-380,124%
Gain YTD50.463-89.733-56%
P/E Ratio39.46N/A-
Revenue35.5B0-
Total Cash1.95B63K3,087,302%
Total Debt11.2B250K4,480,000%
FUNDAMENTALS RATINGS
GNGBY vs IRME: Fundamental Ratings
GNGBY
IRME
OUTLOOK RATING
1..100
7834
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
96
Overvalued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
85100
PRICE GROWTH RATING
1..100
4835
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNGBY's Valuation (16) in the null industry is significantly better than the same rating for IRME (96). This means that GNGBY’s stock grew significantly faster than IRME’s over the last 12 months.

GNGBY's Profit vs Risk Rating (90) in the null industry is in the same range as IRME (100). This means that GNGBY’s stock grew similarly to IRME’s over the last 12 months.

GNGBY's SMR Rating (85) in the null industry is in the same range as IRME (100). This means that GNGBY’s stock grew similarly to IRME’s over the last 12 months.

IRME's Price Growth Rating (35) in the null industry is in the same range as GNGBY (48). This means that IRME’s stock grew similarly to GNGBY’s over the last 12 months.

GNGBY's P/E Growth Rating (12) in the null industry is significantly better than the same rating for IRME (100). This means that GNGBY’s stock grew significantly faster than IRME’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GNGBYIRME
RSI
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
54%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
50%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 13 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
57%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
48%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PTIR32.581.13
+3.59%
GraniteShares 2x Long PLTR Daily ETF
THW11.900.06
+0.48%
abrdn World Healthcare Fund
TOTL40.610.06
+0.15%
SPDR® DoubleLine® Total Return Tact ETF
MEDX29.43-0.15
-0.49%
Horizon Kinetics Medical ETF
SOVF30.48-0.28
-0.90%
Sovereign's Capital Flourish Fund

GNGBY and

Correlation & Price change

A.I.dvisor tells us that GNGBY and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
+0.64%
QDEL - GNGBY
31%
Poorly correlated
-3.58%
ESLOY - GNGBY
28%
Poorly correlated
-0.38%
SAUHY - GNGBY
25%
Poorly correlated
+0.71%
COO - GNGBY
25%
Poorly correlated
-0.74%
SSMXY - GNGBY
24%
Poorly correlated
-0.16%
More

IRME and

Correlation & Price change

A.I.dvisor tells us that IRME and CZMWY have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRME and CZMWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRME
1D Price
Change %
IRME100%
N/A
CZMWY - IRME
28%
Poorly correlated
+0.61%
XAIR - IRME
27%
Poorly correlated
-1.70%
SRTOY - IRME
24%
Poorly correlated
N/A
CZMWF - IRME
21%
Poorly correlated
+1.61%
GNGBY - IRME
11%
Poorly correlated
+0.64%
More